News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
544,806 Results
Type
Article (17119)
Company Profile (178)
Press Release (527503)
Multimedia
Podcasts (35)
Webinars (11)
Section
Business (182233)
Career Advice (542)
Deals (27466)
Drug Delivery (72)
Drug Development (60113)
Employer Resources (30)
FDA (11476)
Job Trends (9851)
News (263245)
Policy (21592)
Tag
2027 BioCapital Standard (2)
2027 BioMidwest Digital (1)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (9)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Digital (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (6)
40 Under 40 (1)
Academia (1131)
Accelerated approval (41)
ADA (22)
Adcomms (12)
Allergies (159)
Alliances (38189)
ALS (169)
Alzheimer's disease (1289)
Antibody-drug conjugate (ADC) (436)
Approvals (11995)
Artificial intelligence (627)
ASCO (203)
Autoimmune disease (330)
Automation (57)
Bankruptcy (272)
Belgium (7)
Best Places to Work (7882)
BIO (51)
Biologics (42)
BIOSECURE Act (19)
Biosimilars (247)
BioSpace Insights (63)
Biotechnology (122)
Bispecific (11)
Bladder cancer (155)
Brain cancer (54)
Breast cancer (656)
Cancer (4813)
Cardiovascular disease (308)
Career advice (461)
Career pathing (14)
CAR-T (230)
CDC (15)
CDMO (84)
Celiac Disease (2)
Cell-line development (2)
Cell therapy (708)
Cervical cancer (38)
Clinical research (54308)
Collaboration (1850)
Commercialization (20)
Company closure (3)
Compensation (1633)
Complete response letters (67)
COVID-19 (1243)
CRISPR (91)
CRO (1)
C-suite (1077)
Cystic fibrosis (120)
Data (7377)
Decentralized trials (1)
Denatured (12)
Depression (118)
Dermatology (127)
Diabetes (447)
Diagnostics (4795)
Digital health (48)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (349)
Drug pricing (50)
Drug shortages (3)
Duchenne muscular dystrophy (249)
Earnings (77010)
Editorial (28)
Employer branding (5)
Employer resources (29)
Events (95801)
Executive appointments (897)
Eye disease (4)
FDA (14848)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (27)
Funding (1396)
Gene editing (191)
Generative AI (53)
Gene therapy (552)
GLP-1 (462)
Government (2102)
Grass and pollen (2)
Guidances (328)
Healthcare (10639)
Hematology (123)
HIV (67)
Huntington's disease (53)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (97)
Immunology and inflammation (212)
Immuno-oncology (100)
Indications (203)
Infectious disease (1504)
Inflammatory bowel disease (196)
Inflation Reduction Act (10)
Influenza (105)
Intellectual property (296)
Interviews (64)
IPO (13136)
IRA (17)
Job creations (2298)
Job search strategy (430)
JPM (13)
Kidney cancer (19)
Kidney disease (76)
Labor market (21)
Layoffs (148)
Leadership (8)
Legal (5498)
Licensing (34)
Liver cancer (57)
Longevity (39)
Lung cancer (676)
Lung diease (9)
Lymphoma (322)
Machine learning (54)
Management (7)
Manufacturing (971)
Marketing (14)
MASH (153)
Medical affairs (2)
Medical device (9229)
Medtech (9409)
Mergers & acquisitions (15514)
Metabolic disorders (973)
mRNA (134)
Multiple sclerosis (167)
Multispecific (2)
NASH (9)
Netherlands (8)
Neurodegenerative disease (358)
Neuropsychiatric disorders (51)
Neuroscience (2557)
Neurotech (1)
NextGen: Class of 2026 (3692)
Non-profit (1400)
Now hiring (32)
Obesity (336)
Opinion (116)
Ovarian cancer (202)
Pain (217)
Pancreatic cancer (264)
Parkinson's disease (306)
Partnered (26)
Patents (572)
Patient advocacy (1)
Patient recruitment (645)
Patient selection (33)
Peanut (61)
People (46687)
Peptides (13)
Pharmaceutical (37)
Pharmacy benefit managers (13)
Phase 1 (17502)
Phase 2 (24026)
Phase 3 (16933)
Pipeline (9612)
Policy (169)
Postmarket research (1737)
Preclinical (7629)
Press Release (69)
Prostate cancer (227)
Psychedelics (23)
Radiopharmaceuticals (233)
Rare diseases (901)
Real estate (3732)
Recruiting (11)
Regenerative medicine (10)
Regulatory (18554)
Reports (32)
Research institute (1182)
Resumes & cover letters (73)
Rett syndrome (48)
RNA editing (18)
RSV (60)
Schizophrenia (134)
Series A (260)
Series B (171)
Service/supplier (5)
Sickle cell disease (85)
Special edition (7)
Spinal muscular atrophy (114)
Sponsored (28)
Startups (2590)
State (1)
Stem cells (1)
Stomach cancer (8)
Substance use disorders (16)
Supply chain (74)
Switzerland (1)
Tariffs (21)
The Weekly (23)
Vaccines (636)
Venture capital (48)
Weight loss (136)
Wet AMD (3)
Women's health (111)
Worklife (3)
Date
Today (67)
Last 7 days (520)
Last 30 days (1891)
Last 365 days (23237)
2026 (17991)
2025 (22587)
2024 (26477)
2023 (30291)
2022 (39071)
2021 (41694)
2020 (37681)
2019 (27170)
2018 (20413)
2017 (21900)
2016 (20929)
2015 (27360)
2014 (23905)
2013 (20081)
2012 (21990)
2011 (22354)
2010 (21596)
Location
Africa (347)
Alabama (90)
Alaska (3)
Arizona (350)
Arkansas (14)
Asia (23839)
Australia (2983)
California (13904)
Canada (3547)
China (972)
Colorado (549)
Connecticut (491)
Delaware (324)
Europe (40123)
Florida (1998)
Georgia (430)
Hawaii (4)
Idaho (53)
Illinois (864)
India (102)
Indiana (400)
Iowa (23)
Japan (511)
Kansas (110)
Kentucky (42)
Louisiana (35)
Maine (43)
Maryland (1543)
Massachusetts (9548)
Michigan (333)
Minnesota (656)
Mississippi (7)
Missouri (104)
Montana (21)
Nebraska (13)
Nevada (137)
New Hampshire (67)
New Jersey (3130)
New Mexico (17)
New York (3329)
North Carolina (1512)
North Dakota (12)
Northern California (7105)
Ohio (356)
Oklahoma (21)
Oregon (31)
Pennsylvania (2495)
Puerto Rico (29)
Rhode Island (41)
South America (544)
South Carolina (82)
South Dakota (1)
Southern California (5678)
Tennessee (140)
Texas (2216)
United States (45773)
Utah (434)
Vermont (1)
Virginia (198)
Washington D.C. (50)
Washington State (1086)
West Virginia (2)
Wisconsin (110)
Wyoming (1)
544,806 Results for "turnstone biologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
August 12, 2026
·
2 min read
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
The agreement, which runs through 2033, comes as Samsung Biologics continues to expand its large manufacturing footprint in South Korea.
September 11, 2026
·
2 min read
·
Nick Paul Taylor
Business
Turnstone Biologics Appoints William Waddill to its Board of Directors
Turnstone Biologics Corp. today announced the appointment of industry veteran William Waddill to the Company’s Board of Directors.
April 16, 2024
·
5 min read
Layoffs
Turnstone Biologics to Lay Off 60% of Workforce, Overhaul C-Suite
Turnstone is shifting resources to focus on clinical advancement of its selected tumor-infiltrating lymphocyte therapy as three C-suite members exit their roles.
October 11, 2024
·
2 min read
·
Angela Gabriel
Biotech Beach
Turnstone Biologics to Participate in Upcoming Investor Conferences - February 21, 2024
Turnstone Biologics Corp. announced that members of its senior management team will participate in the following investor conferences.
February 21, 2024
·
1 min read
Business
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Turnstone Biologics Corp. reported financial results for the first quarter ended March 31, 2024, and provided recent business highlights.
May 13, 2024
·
9 min read
Press Releases
Turnstone Biologics Announces Plans to Explore Strategic Alternatives
February 4, 2025
·
4 min read
Press Releases
NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results
August 31, 2026
·
10 min read
Press Releases
Cellution Biologics Completes Acquisition of SimpliDerm® from Elutia Inc.
August 18, 2026
·
2 min read
Press Releases
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
May 9, 2025
·
4 min read
1 of 54,481
Next